Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 4/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.36 |
| ▸ | FAAH | O00519 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7077372 | 0.88 | PTGS1 (0.47) | MGLLPTGS1PTGS2FAAH | |
| SCHEMBL7073285 | 0.80 | CYP2D6 (0.33) | MGLLPTGS1PTGS2FAAH | |
| SCHEMBL1206903 | 0.68 | CYP2D6 (0.36) | — | |
| Maleic Anhydride SCHEMBL6318484 | 0.65 | CYP2D6 (0.32) | — | |
| SCHEMBL8106173 | 0.65 | PTGS1 (0.32) | PTGS1PTGS2 | |
| SCHEMBL75012 | 0.60 | CYP2C19 (0.33) | — | |
| SCHEMBL9640374 | 0.60 | MGLL (1.00) | MGLLPTGS1PTGS2FAAH | |
| SCHEMBL357623 | 0.60 | MGLL (1.00) | MGLLPTGS1PTGS2FAAH | |
| SCHEMBL36400 | 0.60 | MGLL (1.00) | MGLLPTGS1PTGS2FAAH | |
| SCHEMBL9497658 | 0.60 | MGLL (1.00) | MGLLPTGS1PTGS2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6858371-B2 | Maleimide-photoresist monomers containing halogen, polymers thereof and photoresist compositions comprising the same | HYNIX SEMICONDUCTOR INC. (KR) | 2005-02-22 | — | — | US | claimed |
| US-6852731-B2 | Antiviral compounds | PFIZER (US) | 2005-02-08 | — | — | US | claimed |
| US-20040242884-A1 | ANTIVIRAL COMPOUNDS | PHARMACIA & UPJOHN COMPANY | 2004-12-02 | — | — | US | claimed |
| US-20030013037-A1 | Maleimide-photoresist monomers containing halogen, polymers thereof and photoresist compositions comprising the same | HYNIX SEMICONDUCTOR INC. (KR) | 2003-01-16 | — | — | US | claimed |
| US-6858371-B2 | Maleimide-photoresist monomers containing halogen, polymers thereof and photoresist compositions comprising the same | HYNIX SEMICONDUCTOR INC. (KR) | 2005-02-22 | — | — | US | disclosed |
| US-20030013037-A1 | Maleimide-photoresist monomers containing halogen, polymers thereof and photoresist compositions comprising the same | HYNIX SEMICONDUCTOR INC. (KR) | 2003-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242884-A1 | ANTIVIRAL COMPOUNDS | ZC3HAV1, IRF3, IFNAR1 | MGLL 3692/4885PTGS1 1025/4885PTGS2 2491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.